幼年特发性关节炎患者翻修全膝关节置换术:假体生存率与第二次翻修后的临床结局
多中心回顾性研究纳入63例幼年特发性关节炎患者共70例翻修全膝关节置换术,假体5年、10年、20年生存率分别为86%、75%、70%;平均KOOS JR评分72.8±16.1分,53%达到患者可接受症状状态阈值;使用限制性假体是再翻修的独立危险因素(HR 6.0,95%CI 1.3-28.6,P=0.025)。
要点
- 翻修全膝关节置换术在幼年特发性关节炎患者中10年及20年假体生存率分别为75%和70%。
- 再翻修最常见原因为假体松动/不稳(8例,40%)、疼痛/滑膜炎(8例,40%)和感染(4例,20%)。
- 使用限制性假体与再翻修风险升高相关(HR 6.0,95%CI 1.3-28.6,P=0.025)。
核心结论
- 幼年特发性关节炎患者翻修全膝关节置换术后10年及20年假体生存率一般。
- 患者报告结局与既往报道的翻修全膝关节置换术相似。
- 再翻修风险随限制性假体使用程度增加而升高。
- 作者认为外科医生在咨询和治疗这些患者时应了解这些结局和危险因素。
研究设计与样本
- 多中心回顾性研究,纳入1987年6月1日至2020年9月30日期间接受翻修全膝关节置换术的63例幼年特发性关节炎患者共70例翻修全膝关节置换术。
- 主要结局为长期假体生存率,次要结局为临床结局。
- 患者报告结局评估时间为2020年4月1日至2022年12月31日。
- 平均年龄47岁(范围21至75岁),假体生存率和患者报告结局的平均随访时间均为12年(范围1.2至32.8年)。
- 证据等级IV。
主要发现
- 翻修全膝关节置换术假体生存率在5年时为86%(95%CI 77至94),10年时为75%(95%CI 65至86),20年时为70%(95%CI 59至81)。
- 平均KOOS JR评分为72.8±16.1分,53%(18/34例患者,21/38例膝关节)达到KOOS JR患者可接受症状状态阈值。
- 再翻修的危险因素包括使用限制性假体(HR 6.0,95%CI 1.3至28.6,P=0.025)。
- 再翻修最常见原因为假体松动/不稳(8例膝关节,40%)、疼痛/滑膜炎(8例膝关节,40%)和感染(4例膝关节,20%)。
临床怎么用
- 作者认为外科医生在咨询和治疗幼年特发性关节炎患者第二次翻修时应了解这些结局和危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Juvenile idiopathic arthritis (JIA) is a rare disease that oftentimes requires treatment with total knee arthroplasty (TKA). Although studies have examined the outcomes of primary TKA for this cohort, the literature on 10- and 20-year revision TKA implant survivorship and clinical outcomes is limited. METHODS: A multicenter retrospective review identified 63 patients who underwent 70 revision TKAs between June 1, 1987, and September 30, 2020. The primary and secondary outcomes of interest were long-term implant survivorship and clinical outcomes, respectively. Patient-reported outcomes were assessed between April 1, 2020, and December 31, 2022. The average age was 47 years (range, 21 to 75). The mean follow-up was 12 years (range, 1.2 to 32.8) for both implant survivorship and patient-reported outcomes. RESULTS: Implant survivorship for revision TKA in JIA patients was 86% (95% confidence interval (CI): 77 to 94) at 5 years, 75% (95% CI: 65 to 86) at 10 years, and 70% (95% CI: 59 to 81) at 20 years. The mean Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR) score was 72.8 ± 16.1 points, with 53% (18 of 34 patients, 21 of 38 TKAs) reaching the KOOS JR patient acceptable symptom state threshold. Risk factors for rerevision included the use of constrained prostheses (hazards ratio: 6.0, 95% CI [1.3 to 28.6], P = 0.025). The most common reasons for rerevision were implant loosening/instability (eight TKAs, 40%), pain/synovitis (eight TKAs, 40%), and infection (four TKAs, 20%). CONCLUSIONS: Revision TKA implant survivorship for JIA patients is modest at 10 and 20 years after surgery. Patient-reported outcomes were similar to those previously reported for revision TKA. Rerevision risk increased with higher levels of constraint. Surgeons should be aware of these outcomes and risk factors when counseling and treating these patients the second time around. LEVEL OF EVIDENCE: IV.
引用
- Cheng R, Coxe FR, Chiu YF, et al. Revision Total Knee Arthroplasty for Juvenile Idiopathic Arthritis: Implant Survivorship and Clinical Outcomes the Second Time Around. J Arthroplasty. 2025. PMID: 40107573. doi:10.1016/j.arth.2025.03.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。